Thomas X. Lu

4.9k citations
20 papers · 3.9k · 2 hit papers · h-index 16

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
  • Immunology top 5%
    • IL-33, ST2, and ILC Pathways

Papers in

    • IL-33, ST2, and ILC Pathways 8
    • Immune Cell Function and Interaction 2
    • MicroRNA in disease regulation 6

Thomas X. Lu

20 papers receiving 3.8k citations

Thomas X. Lu's Hit Papers

MicroRNA 2017 · 1.9k citations
1.9k0+5+11Years since publication50010001.5k

Peers

Thomas X. Lu
Comparison fields: 5 of 115
  • Cancer Research 1.6k
  • Immunology 731
  • Molecular Biology 1.9k
  • Rheumatology 371
  • Immunology and Allergy 105
Replace Ilias Alevizos with:
Ilias Alevizos United States
Mariola Kurowska‐Stolarska United Kingdom
Nicole J. Horwood United Kingdom
Guoping Zheng Australia
Mutsumi Miyauchi Japan
Osamu Tokunaga Japan
Sonia B. Jakowlew United States
Giuseppe Pintucci United States
Ting Wen United States
Ken Omura Japan
Thomas X. Lu relative to Ilias Alevizos United States Ilias Alevizos's profile →
Citations per field
00.5×
Ilias Alevizos · 1×
Citations per year

Countries citing papers authored by Thomas X. Lu

Since Specialization
Citations

This map shows the geographic impact of Thomas X. Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas X. Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas X. Lu more than expected).

Fields of papers citing papers by Thomas X. Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas X. Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas X. Lu. The network helps show where Thomas X. Lu may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas X. Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas X. Lu Line = papers co-authored together Thomas X. Lu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
MicroRNA
Hit paper breakdown →
20171890
2
MicroRNA-21 Is Up-Regulated in Allergic Airway Inflammation and Regulates IL-12p35 Expression
Hit paper breakdown →
2009500
3 2007369
4 2011307
5 2013185
6 2012127
7 2020108
8 201577
9 201373
10 201259
11 201348
12 202346
13 201134
14 200929
15 202023
16 202021
17 20149
18 20193
19 20061
20
Mechanisms of asthma and allergic inflammation Rapid publication IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and reversibility with glucocorticoids
20071

About Thomas X. Lu

Thomas X. Lu is a scholar working on Immunology, Cancer Research, Surgery, Molecular Biology and Rheumatology, having authored 20 papers that have together received 3.9k indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (8 papers), MicroRNA in disease regulation (6 papers), Eosinophilic Esophagitis (5 papers), Eosinophilic Disorders and Syndromes (3 papers), DNA Repair Mechanisms (2 papers), Asthma and respiratory diseases (2 papers), Immune Cell Function and Interaction (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (1.6k citations), Immunology (731 citations), Molecular Biology (1.9k citations), Rheumatology (371 citations) and Immunology and Allergy (105 citations). Thomas X. Lu has collaborated with scholars based in United States, China and Russia. Frequent co-authors include Marc E. Rothenberg, Ariel Munitz, Melissa K. Mingler, Bruce J. Aronow, Eun‐Jin Lim, Philip E. Putnam, J. Pablo Abonia, Yi Wu, Susanne I. Wells and Margaret H. Collins. Their work appears in journals such as Journal of Allergy and Clinical Immunology, The Journal of Immunology, Gut, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact